Cirrhosis has a relevant epidemiological and economic impact on hospitalizations and preventive strategies for its clinical management are warranted.
Introduction
Liver cirrhosis is a chronic disease with defined pathophysiological features, associated with a variety of peculiar clinical conditions and characterized by high morbidity and mortality rates [1] . Chronic infection by hepatotropic viruses, alcohol abuse, autoimmunity, and fatty liver associated with obesity and diabetes are the major causes of cirrhosis [2] [3] [4] [5] . Typical features consist of an irreversible chronic injury of hepatic parenchyma and diffuse fibrosis associated with nodular liver regeneration. The development of portal hypertension, due to increased intrahepatic resistance and splanchnic blood flow [6, 7] , is a hallmark in the history of cirrhosis; its presence is associated with the development of severe complications, such as the formation and rupture of esophageal and/or gastric varices, ascites, and hepatic encephalopathy (HE) Keywords Liver cirrhosis · Hospitalization · Epidemiology · Healthcare costs Abstract Background and Aim: Liver cirrhosis is characterized by high morbidity and mortality rates. This study was addressed to evaluate the epidemiological and economic impact of cirrhosis on hospitalizations in a large population in Italy. Methods: Epidemiological analysis was performed using hospital discharge sheets of 57,720 hospitalizations due to liver disease from 2006 to 2008, selected from the Veneto regional archive. In a sample of 100 randomly selected hospitalizations, a detailed cost analysis was performed and a comparison was made with sets of patients admitted for heart failure (HF) and chronic obstructive pulmonary disease (COPD). Results: Among patients with cirrhosis, ascites emerged as the most frequent cause of admission, followed by hepatic encephalopathy, hepatocellular carcinoma, and upper gastrointestinal bleeding. Encephalopathy and ascites were the complications with the highest rates of readmission. The detailed cost analysis of hospitalizations revealed that economic expenses in the set of patients admitted for cirrhosis were about 30% higher than those for patients admitted for HF or COPD, mainly due to the longer duration of hospitalization. Conclusions: [2, 8, 9] . In Italy, liver cirrhosis is one of the main chronic diseases and its prevalence has increased in the last decades, being 1 of the 10 main causes of death [10] . Liver cirrhosis is important in terms of medical, social, and economic implications, with relevant consequences at individual and community level. In fact, quality of life is impaired, while morbidity and mortality rates are increased in patients with cirrhosis [11] [12] [13] . Total costs of liver disease encompass direct medical costs and indirect costs due to loss of productivity. In patients with cirrhosis, the main medical costs are due to new antiviral therapies, treatment of hepatocellular carcinoma (HCC), and liver transplantation [14] [15] [16] .
On the basis of these considerations, the present study was conducted to assess the actual impact of cirrhosis on hospitalizations during a 3-year timeframe in Veneto region, with regard to epidemiology, causes of hospital admission, presence of comorbidities, frequency of readmission, and mortality. A detailed economic analysis of the costs for hospitalization was also performed in a subset of admissions for cirrhosis and it was compared with the results obtained from patients admitted for the most common diseases in the same timeframe.
Methods
Patients resident in the Italian Veneto region and discharged between 2006 and 2008 with ICD9-CM-1997 codes, referring to hospitalizations due to liver disease, were selected from the local archive of hospital discharge sheets. Epidemiological data were analyzed with the support of the Regional Epidemiological System (SER). More detailed parameters including causes of hospitalization, repeated admissions, etiology of cirrhosis, and comorbidities were examined only in the subgroup of patients admitted to the hospitals in the health district of Padova (ULSS 16) with the support of Information Technology Unit of the University Hospital of Padova on the basis of Qlik software platform. A sample of 100 inpatients admitted for cirrhosis (excluding Day Hospital admissions) was randomly selected among patients admitted to the hospitals of the same health district and a detailed cost analysis was performed on the basis of the information achieved from the medical reports. For each hospitalization, expenses were defined by measuring direct costs (individual biochemical and instrumental examinations, medication doses, and all sorts of recorded interventions) and structural costs (transportations, catering, maintenance of machines and spaces, sanitary and non-sanitary employees) extracted from the current cost tables of Padova University Hospital. The results were compared with those obtained in randomly selected patients admitted during the same period for heart failure (HF) or chronic obstructive pulmonary disease (COPD; n = 100 for each group). These 2 diseases were selected because they were more frequently responsible for hospitalization, according to ICD9 discharge sheets. Statistical analysis was performed with GraphPad InStat Program. Comparisons between groups of patients were performed with Fisher's exact test. The null hypothesis was rejected at p < 0.05.
Results

Epidemiologic Features
Hospitalizations due to liver disease in Veneto region between 2006 and 2008 were 57,720 (mean 19,240 per year, prevalence about 0.4% per year). Of the 57,720 admissions, 47,182 were urgent admissions and 10,538 were hospital admissions during day. Since the overall number of patients admitted to hospital during the timeframe of the study was 33,857, patients were hospitalized on an average of 1.7 times per year during the observation time. About 75% of the admissions for liver disease were caused by complications of cirrhosis, with a prevalence of about 0.3% per year.
Patients admitted for liver disease were mostly men (63%) and about 50% of them were younger than 65 years ( Fig. 1 ) . The occurrence of death during urgent admission was reported in 5,751 cases, with a mortality rate of 12.2%. 
Clinical Features
In the study period, 4,339 patients were admitted to the hospitals of ULSS 16 due to liver disease: 3,389 were urgent admissions and 950 day hospital admissions. In this group of patients, the etiology of cirrhosis was alcoholic in 51.9%, while it was non-alcohol-related in 48.1%, likely due mainly to hepatitis virus infections.
When the causes of hospitalization among urgent admissions were analyzed according to all the diagnosis reported in the discharge sheet, ascites emerged as the most frequent complication, HCC ranked second, followed by HE and upper gastrointestinal bleeding ( Fig. 2 ) . When only the first diagnosis was considered, which usually reflects the main cause of admission, HE emerged as the most common complication of cirrhosis responsible for hospitalization ( Fig. 3 ) . HE was also the most commonly reported among patients who were readmitted in hospital during the period of the study (1.5 episodes/year), followed by HCC (1.4 episodes/year), ascites (1.3 episodes/year), and upper gastrointestinal bleeding (1.1 episodes/year). Death occurred in 26.6% of patients admitted for HCC when reported as first diagnosis, in 4.8% of patients admitted for upper gastrointestinal bleeding, in 4.1% of those admitted for HE, and in 0.4% of those admitted for ascites.
Comorbidities
In patients hospitalized for cirrhosis, the association between the complications of cirrhosis and the comorbidities reported in the hospital discharge sheets were evaluated. The most frequent comorbidities recorded were type 2 diabetes, respiratory or urinary infection, and systemic hypertension. We observed a statistically significant association between HE and urinary tract infection (8.6% in patients with HE vs. 1.6% in patients without HE; p = 0.0001), while no significant associations were observed for the other complications.
Cost Analysis
The characteristics of the patients randomly selected for the costs analysis are shown in Table 1 . Compared to patients admitted for HF or COPD, patients hospitalized for liver cirrhosis were younger and the duration of hospitalization was longer, while no statistical difference in mortality rate was observed. The costs of hospitalization of patients admitted for cirrhosis (3,884 ± 3,230 €) was more than 50% higher than that of patients admitted because of HF (2,510 ± 1,199 €; p < 0.01) or COPD (2,713 ± 1,298 €; p < 0.05; Table 1 ). No significant differences were detected among the 3 groups regarding the daily costs; this finding is supported by the results of the detailed analysis of the items that contributed to determine the total expenses of hospitalization, since most of the costs were due to fixed expenses ( Fig. 4 ) . Therefore, the higher total costs observed in patients with cirrhosis were mainly due to the longer duration of hospitalization in this group of patients. It is worth noting that in none of the admissions randomly selected for the cost analysis, the patients underwent liver transplantation. 
Discussion
Cirrhosis is one of the major causes of mortality, accounting for about 10,000 deaths per year in Italy [10] .
This study retrospectively analyzes the epidemiological and economic impact of cirrhosis and its complications on hospital admissions in Veneto, a region in the NorthEast of Italy. The aim of the study was not simply to provide an analysis of hospital admissions due to liver disease, but also to identify the main quantitative and qualitative aspects of hospitalizations to promote future planning processes and to evaluate their economic impact. First of all, it should be emphasized that about half of patients who were admitted because of liver disease were still of working age, highlighting its social and economic relevance.
Although alcohol consumption is higher in Northern Italy than in the Southern regions, where viral etiology is accountable for most of the cases, we believe that the data presented in this study can be generalized to the whole country. In fact, in 2002, the mortality for cirrhosis in Veneto region was similar to that of national data (18 vs. 18.4 per 100.000 inhabitants) [10] . Despite the prevalence of alcohol use disorders and dependence in Italy being lower than the average of European countries, alcohol consumption is still one of the main factors responsible for morbidity and mortality in patients with cirrhosis [17] , accounting for 43% in women and 51% in men [10] . Our data confirm the importance of alcohol as etiological factor, since it was identified in 51.9% of the patients hospitalized for cirrhosis. Most of the non-alcoholic cirrhosis was probably of viral origin, but it should also be taken into consideration the continuous rise in obesity and type 2 diabetes in the Italian population and the associations of these conditions with non-alcoholic fatty liver disease [18] .
Clinical consequences of portal hypertension, including ascites, variceal bleeding, HE, and hepatorenal syn- drome, are usually the underlying causes of hospitalization in patients with cirrhosis. In our study, HE and ascites were the complications most frequently reported as the first cause of hospitalization. These data are in line with the findings described in the study of Schmidt et al. [19] . Moreover, in our study, HE emerged as the complication responsible for the highest rate of repeated hospital admissions. Since HE was significantly associated with urinary tract infections, the presented data underline the need to develop strategies aimed at the prevention and/or early control of urinary infections among patients with cirrhosis. We cannot exclude that the incidence of urinary infections among patients admitted with HE was higher than in the overall population of patients with cirrhosis due to the fact that in these patients urinary testing is more frequently requested, since infections are known precipitant causes. Mortality rate of patients admitted for cirrhosis was of about 12%. This rate might seem rather high if compared to the 7.4% reported in a study analyzing a large representative sample of patients hospitalized for cirrhosis in US from 2002 to 2010 [20] . Even if a comparison between 2 distinct populations during 2 different intervals of time is difficult, considering the fact that in the American cohort of patients with cirrhosis the mean duration of hospitalization was almost half, we could speculate that the earlier discharge might also implicate an increase of the number of patients who died outside the hospital, artificially reducing the in-hospital mortality statistics. In fact, the number of patients discharged to hospice progressively increased from 2002 to 2010. Moreover, in our cohort, inpatient mortality was particularly high among patients admitted because of HCC (26.6%).
The analysis addressed to evaluate the costs of hospitalizations revealed that in patients admitted for cirrhosis the overall expenses were significantly higher than those of patients admitted for HF or COPD. It should be noted that the mean refund received by diagnosis-related groups for hospitalizations due to cirrhosis and its complications corresponded to 66.3% of its calculated actual costs, while HF and COPD were refunded at 106.6 and 88.5% of their calculated actual cost, respectively. Therefore, the present study suggests an underestimation of the economic impact of hospitalizations due to advanced liver disease on the Italian national healthcare system and this aspect should be considered for future health policy planning. This is a very important issue if we consider the present concerns related to the standard of care for hepatitis C, having the new direct antiviral agents offered higher sustained virological response rates but with substantial costs increase [20] . The annual costs for the treatment of patients with decompensated cirrhosis are substantially higher than those for patients in a compensated stage of the disease [21] ; therefore, a cost-effective evaluation of cirrhosis-related complications should also be carefully taken into account when considering the longterm cost-effectiveness of antiviral treatment. This is particularly true if we consider that a large part of the patients hospitalized for cirrhosis complications were individuals of working age. In addition, it should be pointed out that the comparison in the cost analysis was performed only among inpatients for ordinary admissions, while treatments for HCC, such as transarterial chemoembolization or radiofrequency ablation, in Italy are usually performed during day hospital admissions, while chemotherapies are performed in outpatient settings. Therefore, the total expenses for the treatment of patients with liver cirrhosis and HCC are probably much higher than those estimated on the basis of inpatients admissions. This highlights even more strongly the relevant impact of liver cirrhosis on the costs for the National Healthcare System.
A potential limitation of our study lies with the methodological approach, since the information was achieved retrospectively from the discharge sheets recorded by the hospital doctors; we cannot exclude that the accuracy of the reports of patients clinical data might have been not so accurate in some cases. Therefore, it is likely that the real impact of advanced liver disease on hospitalizations was even underestimated by our data. For the same reason, it is possible that the main cause of hospitalization was not reported properly in the discharge sheet. This might explain why in the present series of data, HE was the most frequent reported cause of hospitalization, while in another study, among 100 patients with cirrhosis admitted at the Padua Teaching Hospital, ascites had emerged as the main cause of hospitalization [22] . Lastly, we have to take into account that in patients with upper gastrointestinal bleeding, other causes than variceal rupture could have caused the hemorrhage, explaining the apparently low percentage of related death (4.8%).
It should be highlighted that in this study the clinical features of patients with decompensated cirrhosis, who are a subgroup of the overall population of cirrhotic patients, are depicted, since patients in a compensated stage generally do not require admission to hospital.
In conclusion, the main contribution of this study is to focus on the impact of cirrhosis and its complications on hospitalizations in a large cohort of Italian patients. The obtained data underline the social and economic implica-tions of this chronic disease and the development of healthcare strategies for better policy choices at national level are warranted.
